Vivani Medical Announces Presentation at the Emerging Growth Conference
Vivani Medical, Inc. (NASDAQ: VANI), a groundbreaking clinical-stage biopharmaceutical company, is gearing up for a significant presentation at the Emerging Growth Conference. This event is set to take place on September 25. During this online presentation, Vivani aims to shed light on its innovative approach to drug delivery through its unique miniature, ultra-long-acting drug implants.
Invitation to Investors and Analysts
Vivani extends an open invitation to both individual and institutional investors, advisors, and analysts to engage in this interactive event. President and CEO Adam Mendelsohn, Ph.D., will lead the session, offering a comprehensive overview of the company and its advancements in biopharmaceutical technology. An interactive Q&A session will follow the presentation, encouraging attendees to submit their questions ahead of time.
Engage with the Company
For those interested in submitting inquiries, Vivani encourages all questions to be sent in advance via email. This direct engagement will ensure that investors and stakeholders can connect meaningfully with the leadership team.
Presentation Details
The live presentation is scheduled for 30 minutes, starting at 1:45 PM Eastern Time. Attendees are encouraged to register early to secure their spot and receive updates pertaining to the event. Registration details are streamlined to facilitate easy access for all participants.
Post-Event Access
For those unable to attend the live session, Vivani Medical plans to make an archived webcast available shortly after the conference. This recording will be accessible on EmergingGrowth.com and the official YouTube channel for interested parties to revisit the insights shared during the presentation.
Understanding the Emerging Growth Conference
The Emerging Growth Conference is an invaluable platform for public companies like Vivani to communicate their innovations and major announcements. Through efficient online presentations, companies can reach a diverse audience of individual and institutional investors. This includes investment advisors and analysts who are keen on discovering the latest developments in dynamic growth sectors.
Broad Reach and Focus
The conference covers a broad range of sectors, featuring companies with robust management teams and innovative product offerings. The aim is to connect companies with potentially thousands of investors, facilitating vital discussions about long-term growth strategies and market execution.
About Vivani Medical, Inc.
Vivani Medical is at the forefront of developing biopharmaceutical implants that aim to revolutionize how medications are delivered. Leveraging its proprietary NanoPortal™ technology, the company focuses on creating implants designed to release drug molecules consistently over extended time frames. This innovative approach is geared towards improving patient adherence and tolerance to essential medications.
Innovating for Patients
Vivani is actively working on GLP-1 based implants targeted for metabolic diseases, including obesity and type 2 diabetes. These implants are designed to mitigate challenges associated with frequent administration of traditional medications, ultimately improving patient outcomes.
Company Contact Information
For further inquiries regarding the presentation or company operations, interested parties can reach out to:
Donald Dwyer
Chief Business Officer
info@vivani.com
(415) 506-8462
Jami Taylor
Investor Relations Advisor
investors@vivani.com
(415) 506-8462
Sean Leous
ICR Healthcare
Sean.Leous@ICRHealthcare.com
(646) 866-4012
Frequently Asked Questions
What is the focus of Vivani Medical?
Vivani Medical focuses on innovative drug delivery systems using miniature implants aimed at enhancing patient adherence to treatment protocols.
What event will Vivani Medical be presenting at?
Vivani Medical will be presenting at the Emerging Growth Conference, showcasing their advancements in biopharmaceutical technology.
Who will be presenting on behalf of Vivani Medical?
Adam Mendelsohn, Ph.D., the President and CEO of Vivani Medical, will lead the presentation and engage with attendees.
How can investors connect with Vivani Medical?
Investors can submit questions in advance via email to ensure their inquiries are addressed during the presentation.
What is the NanoPortal™ technology?
NanoPortal™ technology is Vivani's proprietary platform designed to create drug delivery implants that release medications steadily, improving patient experience and adherence.
